ClinicalTrials.govpublic full text
Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency
ovarian cancer, brcawt, homologous recombination deficiency (hrd), parp inhibitors, homologous recombination repair (hr), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 882344
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.